News Shock as AstraZeneca’s charismatic cancer R&D chief José Bas... AstraZeneca is mourning the loss of one of its top scientists after eminent cancer researcher José Baselga passed away at the age of just 61.
News AZ appoints controversial doctor to lead new oncology unit AstraZeneca has a new and controversial oncology head after the departure of two key leaders led to a management reshuffle.
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.